A phase II study of BEZ235 in patients with everolimusresistant, advanced pancreatic neuroendocrine tumours

Nicola Fazio, Roberto Buzzoni, E. Baudin, Lorenzo Antonuzzo, Richard A. Hubner, Harald Lahner, Wouter De Herder, Markus Raderer, A. Teulé, Jaume Capdevila, Steven K. Libutti, Matthew H. Kulke, Manisha Shah, Debarshi Dey, Sabine Turri, Paola Aimone, Cristian Massacesi, Chris Verslype

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A phase II study of BEZ235 in patients with everolimusresistant, advanced pancreatic neuroendocrine tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences